LRRK2 and Parkinson disease: This data shows that PD mutations affect tau pathology in a mutation type specific manner, with both SNCA A53T and LRRK2 R1441G mutations having increased numbers of tau puncta in dopamine neurons, while PRKN lof did not display tau pathology.